loading

Myriad Genetics Inc Azioni (MYGN) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
2.85%
202.20
196.60 191.90 183.50 181.20
Cost Of Revenue
64.60
- 57.60 57.80 59.20
Gross Profit
137.60
- 134.30 125.70 122.00
Operating Expenses
58.89%
165.50
402.60 194.40 239.40 174.20
Interest Income/Expense
44.44%
0.50
0.90 1.00 0.50 0.50
Benefits Costs and Expenses
0.35%
228.10
228.90 253.10 299.60 233.80
Costs And Expenses
0.92%
230.10
228.00 252.00 297.20 233.40
Depreciation and Amortization
3.97%
15.70
15.10 14.10 13.30 19.40
Operating Income/Loss
11.15%
-27.90
-31.40 -60.10 -113.70 -52.20
Nonoperating Income/Loss
322.22%
2.00
-0.90 -1.10 -2.40 -0.40
Income/Loss From Continuing Operations Before Tax
19.81%
-25.90
-32.30 -61.20 -116.10 -52.60
Income Tax Expense/Benefit
109.09%
0.10
-1.10 0.10 - 2.10
Income/Loss From Continuing Operations After Tax
16.67%
-26.00
-31.20 -61.30 -116.10 -54.70
Net Income/Loss
16.67%
-26.00
-31.20 -61.30 -116.10 -54.70
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
7,392%
89.90
1.20 81.90 81.70 81.30
Diluted Average Shares
7,392%
89.90
1.20 81.90 81.70 81.30
Basic Earnings Per Share
14.71%
-0.29
-0.34 -0.75 -1.42 -0.67
Diluted Earnings Per Share
14.71%
-0.29
-0.34 -0.75 -1.42 -0.67
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
diagnostics_research LH
$239.67
price down icon 0.21%
$167.26
price down icon 1.24%
diagnostics_research WAT
$373.47
price up icon 1.35%
$140.14
price up icon 2.30%
diagnostics_research MTD
$1,217.97
price up icon 1.77%
$417.24
price down icon 0.31%
Capitalizzazione:     |  Volume (24 ore):